Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma.

Indeed, a recent report suggested that the CTNNB1 class of HCC belonged to the HCC subtype that might obtain less benefit by sorafenib when used as a neoadjuvant, although its involvement did not reach statistical significance.

also in 111,027 other papers